I.e., RSLS is essentially getting paid for its Nasdaq listing and nothing more.
…Vyome Therapeutics, Inc. is a clinical stage specialty pharmaceutical company working to treat immuno-inflammatory diseases including rare indications of unmet need… RSLS is yet another “serial” reverse-merger company, having been created by a reverse-merger with OBLN in 2021 (#msg-161068114).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.